ClinConnect ClinConnect Logo
Search / Trial NCT04778124

HAL-RAR Technique for Treating Hemorrhoids

Launched by AMALIA FLEMING GENERAL HOSPITAL · Feb 26, 2021

Trial Information

Current as of April 28, 2025

Completed

Keywords

Hemorrhoidal Disease Treatment Hal Rar Mucopexy

ClinConnect Summary

This is a retrospective, single-institution, study conducted from January 2010 to November 2019. Grade of hemorrhoidal disease was assessed according to Goligher's classification. Patients with grade II, resistant to conservative treatment, grade III and IV hemorrhoidal disease that underwent the HAL-RAR technique, were included in the study. Patients with grade II disease presented a small degree of prolapse. Non-surgical techniques, such as rubber-band ligation or injection of sclerosing agents, were not performed prior to the HAL-RAR operation since this is not a common practice in our i...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with
  • grade II hemorrhoidal disease, resistant to conservative treatment
  • grade III hemorrhoidal disease,
  • grade IV hemorhoidal disease,
  • that underwent the HAL-RAR technique.
  • Exclusion Criteria:
  • pregnancy
  • coagulation disorders
  • patients with major comorbidities (American Society of Anesthesiologists \[ASA\] ≥3),
  • psychiatric conditions preventing collaboration and follow-up
  • other concomitant anorectal disease (rectal prolapse, anal fissure, anal stenosis, perianal fistula or abscess, fecal incontinence)
  • previous pelvic radiotherapy
  • declined consent

About Amalia Fleming General Hospital

Amalia Fleming General Hospital is a prominent healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence, the hospital integrates a multidisciplinary approach, harnessing the expertise of leading medical professionals and researchers. The facility is equipped with state-of-the-art technology, ensuring the highest standards of safety and efficacy in clinical research. Amalia Fleming General Hospital aims to contribute to the development of new therapies and treatments, enhancing health outcomes for diverse patient populations.

Locations

Patients applied

0 patients applied

Trial Officials

Georgia Dedemadi, MD, PhD

Principal Investigator

Amalia Fleming Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials